Bapineuzumab for Mild to Moderate Alzheimer’s Disease: A Meta-Analysis of Randomized Controlled Trials
BMC Neurology - United Kingdom
doi 10.1186/s12883-017-0850-1
Full Text
Open PDFAbstract
Available in full text
Date
April 4, 2017
Authors
Publisher
Springer Science and Business Media LLC